ARLZQ
|
My thoughts are we'd be rich if Harris hadn't sold out Tribute...
|
ARLZQ
|
Whatever happens tomorrow will be nothing but a short term fluctuation...
|
ARLZQ
|
One thing I learned from the Tribute saga is, and I hope I have some capital...
|
ARLZQ
|
You think Deerfield etc financed this operation to the tune of 150 million+ &...
|
ARLZQ
|
Horizon royalties to ARLZ have floor values; but everyone knows Yosprala is...
|
ARLZQ
|
This is probably one of those times where as soon as I open my mouth, the...
|
ARLZQ
|
IBB is up 2.5% and Valeant on the NYSE is down over 4% so perhaps the whole...
|
ARLZQ
|
I'll predict Yosprala approval on Thursday. I'm basing this off...
|
ARLZQ
|
Nah, cash burn rate is well known and Fibricor numbers might surprise.
|
ARLZQ
|
At least we don't have any UK exposure right now, unlike Merus and...
|
ARLZQ
|
Anyone getting tempted by Barclays??
|
ARLZQ
|
This might have had something to do with biotech volatility on Tuesday...
|
ARLZQ
|
Well, Adams has about 3 million in paper losses since his share purchase, so...
|
ARLZQ
|
I dunno, nothing has changed since the announcement of the merger other than...
|
ARLZQ
|
I thought that would have been an odd matchup.
|
ARLZQ
|
I think their big thing is something called QLT09100, a retinoid drug worth...
|
ARLZQ
|
They have some tax credits, some fast tracked drugs in the pipeline and about...
|
ARLZQ
|
Would be an unusual merger, given Adam's previous lauding of having a...
|
ARLZQ
|
Picked up a few more shares this morning. Sucker for punishment :)
|
ARLZQ
|
Who knows. I don't lose any sleep over trading based on nothing, it...
|